Join the Weight Loss (Obesity / Overweight) group to help and get support from people like you.
Weight Loss (Obesity / Overweight) News (Page 3)
Related terms: Weight Gain, Overweight, Weightloss, Anorexiants, Obesity, Obese, Weight Loss, Loose Weight, Lost Weight, diet drugs, diet medications, anti-obesity medications, Weight Loss Medications
Roux-en-Y Gastric Bypass, Sleeve Gastrectomy Beat Adjustable Gastric Banding for Severe Obesity
THURSDAY, April 10, 2025 – For adults with severe obesity, Roux-en-Y gastric bypass and sleeve gastrectomy are more effective than adjustable gastric banding, according to a study published online...
2018 to 2022 Saw Increase in GLP-1 Receptor Agonist Use in Adults Without Diabetes
THURSDAY, April 10, 2025 – Among U.S. adults without diabetes, the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) increased from 2018 to 2022, reaching annual prevalence of 0.4 percent...
Semaglutide Ups Risk for Nonarteritic Anterior Ischemic Optic Neuropathy in Diabetes
TUESDAY, April 8, 2025 – For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published...
Biden Plan to Expand Obesity Drug Coverage Is Rejected
MONDAY, April 7, 2025 – The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped...
Lifestyle Changes Boost Longevity For Cancer Survivors
FRIDAY, April 4, 2025 – Cancer survivors can reduce their ongoing risk of death by sticking to diet and exercise guidelines recommended by the American Cancer Society, a new study suggests....
Rise in Prevalence of Obesity in Youth, Adults With T1DM Seen From 2008 to 2023
FRIDAY, April 4, 2025 – From 2008-2011 to 2020-2023, there was an increase in the prevalence of obesity among youth and adults with type 1 diabetes, and glucagon-like peptide 1 receptor agonist...
ACP: Switching From Dulaglutide to Tirzepatide Improves HbA1c Reduction in T2DM
FRIDAY, April 4, 2025 – For patients with inadequately controlled type 2 diabetes receiving dulaglutide, switching to tirzepatide is associated with additional hemoglobin A1c (HbA1c) reduction and...
Maternal Influences Have Persistent Impact on Offspring Obesity
THURSDAY, April 3, 2025 – Maternal influences have a persistent effect on offspring obesity through age 42 years, according to a study published online March 26 in PLOS ONE. Glenna Nightingale,...
Lawmakers Want School Meal Programs to Allow Whole Milk Again
WEDNESDAY, April 2, 2025 – Whole and 2 percent milk may be coming back to school lunch trays, more than a decade after being removed to help reduce childhood obesity, The Associated Press reported....
Zepbound Now Available Through Hims & Hers
WEDNESDAY, April 2, 2025 – The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform. The company said Tuesday it now provides access...
Weight Loss Greater With Intermittent Fasting Than Calorie Restriction
MONDAY, March 31, 2025 – An intermittent fasting (IMF) intervention yields modestly greater weight loss than daily caloric restriction (DCR) among adults with overweight or obesity, according to a...
Fasting Outperforms Calorie Cutting, Clinical Trial Says
TUESDAY, April 1, 2025 – Fasting every other day can prompt more weight loss than simply cutting calories, a new clinical trial shows. People who undertook 4:3 intermittent fasting lost just under...
GLP-1 Drug Use For Weight Loss Has Soared, Costing Billions
TUESDAY, April 1, 2025 – The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent years, a new study says. The number of people...
More Type 1 Diabetics Are Obese, Taking GLP-1 Drugs
MONDAY, March 31, 2025 – Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new...
Sugar Substitute Appears To Boost Appetite, Hunger
FRIDAY, March 28, 2025 – Splenda doesn’t directly add calories to your diet, but the sweetener still might lead people to pack on pounds, a new study says. The sugar substitute might spur on a p...
Further information
Related drug support groups
bupropion, phentermine, Contrave, Ozempic, amphetamine, Saxenda, methamphetamine, Mounjaro, topiramate, view more... Wegovy, semaglutide, methylphenidate, Qsymia, Zepbound, liraglutide, tirzepatide, Adipex-P, Alli, orlistat, garcinia cambogia, desvenlafaxine, dulaglutide